Special Issue "Shiga Toxin"
QuicklinksA special issue of Toxins (ISSN 2072-6651).
Deadline for manuscript submissions: closed (30 April 2011)
Special Issue Editor
Guest Editor
Prof. Dr. Clifford A. Lingwood
Division of Molecular Structure and Function, Research Institute, The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada
Website: http://www.sickkids.ca/AboutSickKids/Directory/People/L/Clifford-Lingwood-staff-profile.html
E-Mail: cling@sickkids.ca
Phone: +1 416 8135998
Fax: +1 416 8135993
Special Issue Information
Dear Colleagues,
Gastrointestinal Shiga toxin (Stx) producing E. coli (STEC) infections are the major cause of the hemolytic uremic syndrome (HUS). This nephropathy remains a significant pediatric health hazard world-wide, for which there is still no specific therapy. The lack of appropriate animal models has hampered therapeutic progress. Other than age (most HUS occurs in the very young), risk factors for HUS following STEC infection have yet to de identified. Cattle provide an animal STEC reservoir and fecal contaminated foodstuffs remain the major infection source. Stx is an AB5 subunit toxin. The pentamer of (small) B subunits binding to its receptor glycosphingolipid(GSL), globotriaosyl ceramide(Gb3) in glomerular endothelial cell membranes, initiates A subunit-mediated cell death leading to HUS, but induction of inflammatory pathways is also key. Gb3 is heterogenous in its lipid structure and membrane organization, such that different Gb3 formats are differentially recognized by Stx family members, particularly Stx2, which is more frequently associated with clinical disease.
Stx binding to Gb3 also provides a biological probe of membrane GSL organization and intracellular vesicular retrograde transport. Internalization of the Stx-Gb3 complex by clathrin dependent and independent means can result in transit via endosomes, trans Golgi network and Golgi, to the endoplasmic reticulum, necessary for subunit separation and A subunit cytosolic translocation. The A subunit is an RNA glycanase which depurinates cytosolic 28S ribosomal subunits to inhibit protein synthesis. Signalling cascades which initiate apoptosis are also found downstream of Stx cell membrane Gb3 binding. The association of Gb3 with cholesterol can result in Stx binding to cell membrane lipid microdomains or rafts which is central to both signal transduction and cytotoxicity.
Stx also has antineoplastic activity due to Gb3 upregulation, and the B subunit can be used for tumour targeting.
Prof. Dr. Clifford A. Lingwood
Guest Editor
Submission
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed Open Access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 800 CHF (Swiss Francs).
Keywords
- hemolytic uremic syndrome
- cytokines
- retrograde transport
- endothelial cells
- glycosphingolipid
Published Papers (5 papers)
|
Toxins 2011, 3(6), 608-625; doi:10.3390/toxins3060608
Received: 3 May 2011; in revised form: 9 June 2011 / Accepted: 9 June 2011 / Published: 14 June 2011
Show/Hide Abstract
| Download PDF Full-text (336 KB) | Download XML Full-text |
|
Toxins 2011, 3(6), 626-639; doi:10.3390/toxins3060626
Received: 20 April 2011; in revised form: 2 June 2011 / Accepted: 7 June 2011 / Published: 14 June 2011
Show/Hide Abstract
| Download PDF Full-text (257 KB) | Download XML Full-text |
|
Toxins 2011, 3(6), 640-646; doi:10.3390/toxins3060640
Received: 3 May 2011; in revised form: 10 June 2011 / Accepted: 14 June 2011 / Published: 16 June 2011
Show/Hide Abstract
| Download PDF Full-text (219 KB) | Download XML Full-text |
|
Toxins 2011, 3(6), 672-677; doi:10.3390/toxins3060672
Received: 12 April 2011; in revised form: 1 June 2011 / Accepted: 8 June 2011 / Published: 20 June 2011
Show/Hide Abstract
| Download PDF Full-text (149 KB) | Download XML Full-text |
|
Toxins 2011, 3(9), 1065-1088; doi:10.3390/toxins3091065
Received: 14 July 2011; in revised form: 16 August 2011 / Accepted: 19 August 2011 / Published: 25 August 2011
Show/Hide Abstract
| Download PDF Full-text (525 KB) | Download XML Full-text |
Last update: 17 November 2011
